Literature DB >> 25973122

Basal cell adenoma of nasal septum: report of a case and review of literature.

Qinying Wang1, Haihong Chen1, Shenqing Wang1.   

Abstract

Basal cell adenoma is an uncommon benign salivary gland neoplasm, presenting isomorphic basaloid cells with a prominent basal cell layer. Basal cell adenoma arising from the nasal septum is exceptionally rare. Reports on positron emission tomography with 2-deoxy-2-fluorine-18-fluoro-D-glucose (18FDG-PET) imaging for basal cell adenoma are limited. Here, we present the case of a 49-year-old man who had the symptoms of intermittent repeated bleeding from the left nose for half a year. 18FDG-PET scanning showed increased accumulation of 18FDG with its characteristic benign pathology has a potential to malignancy. After removal of the mass, the patient became symptom free. Pathology showed basal cell adenoma. The evidence of active and growing cells was present in the specimen.

Entities:  

Keywords:  Basal cell adenoma; PET/CT; nasal septum

Mesh:

Year:  2015        PMID: 25973122      PMCID: PMC4396301     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  12 in total

1.  F-18 FDG PET/CT of a uterine smooth-muscle tumor of unknown malignant potential.

Authors:  Il Ki Hong; Deog Yoon Kim
Journal:  Clin Nucl Med       Date:  2011-10       Impact factor: 7.794

2.  Carcinoma in basal cell adenoma of the parotid gland.

Authors:  T Nagao; I Sugano; Y Ishida; O Matsuzaki; A Konno; Y Kondo; K Nagao
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

3.  [Basal cell adenoma of the salivary glands].

Authors:  O Kleinsasser; H J Klein
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1967

4.  A combined PET/CT scanner for clinical oncology.

Authors:  T Beyer; D W Townsend; T Brun; P E Kinahan; M Charron; R Roddy; J Jerin; J Young; L Byars; R Nutt
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

5.  Immunohistochemical aspects of basal cell adenoma and canalicular adenoma of salivary glands.

Authors:  S O Machado de Sousa; N Soares de Araújo; L Corrêa; A M Pires Soubhia; V Cavalcanti de Araújo
Journal:  Oral Oncol       Date:  2001-06       Impact factor: 5.337

6.  F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma.

Authors:  Shunsuke Tanabe; Yoshio Naomoto; Yasuhiro Shirakawa; Yasuhiro Fujiwara; Kazufumi Sakurama; Kazuhiro Noma; Munenori Takaoka; Tomoki Yamatsuji; Takao Hiraki; Yoshihiro Okumura; Masahiko Mitani; Mitsumasa Kaji; Susumu Kanazawa; Toshiyoshi Fujiwara
Journal:  Clin Nucl Med       Date:  2011-10       Impact factor: 7.794

7.  Histopathologic studies of basal cell adenoma of the parotid gland.

Authors:  K Nagao; O Matsuzaki; H Saiga; I Sugano; H Shigematsu; T Kaneko; T Katoh; T Kitamura
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

8.  18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.

Authors:  Felipe A Calvo; Marta Domper; Raúl Matute; Raúl Martínez-Lázaro; José A Arranz; Manuel Desco; Emilio Alvarez; José Luis Carreras
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

Review 9.  Classification and differential diagnosis of clear and basal cell tumors of the salivary glands.

Authors:  G Seifert
Journal:  Semin Diagn Pathol       Date:  1996-05       Impact factor: 3.464

10.  WHO International Histological Classification of Tumours. Tentative Histological Classification of Salivary Gland Tumours.

Authors:  G Seifert; C Brocheriou; A Cardesa; J W Eveson
Journal:  Pathol Res Pract       Date:  1990-10       Impact factor: 3.250

View more
  1 in total

Review 1.  Basal cell adenoma in the parapharyngeal space resected via trans-oral approach aided by endoscopy: Case series and a review of the literature.

Authors:  Ting-Ting Wu; Yang-Yang Bao; Shui-Hong Zhou; Qin-Ying Wang; Li-Fang Shen
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.